Michael Bani
@michaelbani.bsky.social
Director at Pharma Now | Co-Founder & CTO at Omnicon Instruments | 50YP @ ICCCS | Techie Pursuing Innovation
Russia’s mRNA cancer vaccine is coming in 2025! It fights tumors and reduces metastasis. Could this be the future of cancer treatment? Stay tuned! #CancerVaccine #CancerResearch #MedicalBreakthrough #Cancer #Tumor #Oncology #mRNA #CancerTreatment #HealthNews #ScienceBreakthrough #AI
December 18, 2024 at 9:14 PM
Russia’s mRNA cancer vaccine is coming in 2025! It fights tumors and reduces metastasis. Could this be the future of cancer treatment? Stay tuned! #CancerVaccine #CancerResearch #MedicalBreakthrough #Cancer #Tumor #Oncology #mRNA #CancerTreatment #HealthNews #ScienceBreakthrough #AI
Regeneron’s EYLEA HD just hit a milestone in treating retinal vein occlusion! Fewer injections, same vision gains. Is this the future of eye care? #EyleaHD #EyeHealth #VisionCare #MedicalBreakthrough #RetinalVeinOcclusion #EyeCare #Vision #HealthNews #ClinicalTrials #MedicalInnovation #ForYou #FYP
December 18, 2024 at 9:13 PM
Regeneron’s EYLEA HD just hit a milestone in treating retinal vein occlusion! Fewer injections, same vision gains. Is this the future of eye care? #EyleaHD #EyeHealth #VisionCare #MedicalBreakthrough #RetinalVeinOcclusion #EyeCare #Vision #HealthNews #ClinicalTrials #MedicalInnovation #ForYou #FYP
First-ever UKidney transplant completed! United Therapeutics is solving organ shortages with genetically engineered pig kidneys. A life-changing breakthrough! #OrganTransplant #UKidney
#MedicalNews #HealthBreakthrough #OrganDonation #KidneyTransplant #Xenotransplantation #GeneticEngineering
#MedicalNews #HealthBreakthrough #OrganDonation #KidneyTransplant #Xenotransplantation #GeneticEngineering
December 18, 2024 at 8:46 PM
First-ever UKidney transplant completed! United Therapeutics is solving organ shortages with genetically engineered pig kidneys. A life-changing breakthrough! #OrganTransplant #UKidney
#MedicalNews #HealthBreakthrough #OrganDonation #KidneyTransplant #Xenotransplantation #GeneticEngineering
#MedicalNews #HealthBreakthrough #OrganDonation #KidneyTransplant #Xenotransplantation #GeneticEngineering
BIG news for lung cancer patients in China! Merck’s KEYTRUDA is now approved for earlier stages of NSCLC, showing incredible results in survival and recurrence reduction. #CancerNews #Immunotherapy #Cancer #LungCancer #CancerResearch #Tumor #CancerTreatment #Healthcare #Immunotherapy
December 17, 2024 at 9:35 PM
BIG news for lung cancer patients in China! Merck’s KEYTRUDA is now approved for earlier stages of NSCLC, showing incredible results in survival and recurrence reduction. #CancerNews #Immunotherapy #Cancer #LungCancer #CancerResearch #Tumor #CancerTreatment #Healthcare #Immunotherapy
Reviva’s Brilaroxazine shows long-term symptom relief in schizophrenia patients! Positive Phase 3 results bring hope to millions. Follow for more updates on breakthroughs! #Schizophrenia #MentalHealthAwareness #ClinicalTrials #Schizophrenia #MentalHealth #PharmaNews #Healthcare #MentalHealthMatters
December 17, 2024 at 9:33 PM
Reviva’s Brilaroxazine shows long-term symptom relief in schizophrenia patients! Positive Phase 3 results bring hope to millions. Follow for more updates on breakthroughs! #Schizophrenia #MentalHealthAwareness #ClinicalTrials #Schizophrenia #MentalHealth #PharmaNews #Healthcare #MentalHealthMatters
Foghorn Therapeutics pauses FHD-286 development but invests in innovative new cancer treatments, including partnerships with Lilly. Exciting progress ahead! Follow for more biotech news! #CancerResearch #Oncology #BiotechNews #Cancer #Biotech #Leukemia #ClinicalTrials #Healthcare #PharmaNews
December 17, 2024 at 9:31 PM
Foghorn Therapeutics pauses FHD-286 development but invests in innovative new cancer treatments, including partnerships with Lilly. Exciting progress ahead! Follow for more biotech news! #CancerResearch #Oncology #BiotechNews #Cancer #Biotech #Leukemia #ClinicalTrials #Healthcare #PharmaNews
GSK’s Jemperli is changing the game for rectal cancer treatment! A 100% response rate without chemo or surgery—this is huge. Follow for more updates! #CancerTreatment #MedicalBreakthrough #FDAApproval #Cancer #CancerResearch #RectalCancer #Tumor #Oncology #Jemperli #FDA #HealthNews #PharmaNews
December 16, 2024 at 11:18 PM
GSK’s Jemperli is changing the game for rectal cancer treatment! A 100% response rate without chemo or surgery—this is huge. Follow for more updates! #CancerTreatment #MedicalBreakthrough #FDAApproval #Cancer #CancerResearch #RectalCancer #Tumor #Oncology #Jemperli #FDA #HealthNews #PharmaNews
Exciting news! Celltrion's biosimilars could soon treat retinal disorders, arthritis, and more across Europe. Affordable healthcare for all! #Biosimilar #AffordableHealthcare #ForYou #HealthNews #MedicalBreakthrough #Biosimilars #ForYouPage #FYP #HealthcareInnovation #Medicine #HealthUpdates #ForYou
December 16, 2024 at 11:14 PM
Exciting news! Celltrion's biosimilars could soon treat retinal disorders, arthritis, and more across Europe. Affordable healthcare for all! #Biosimilar #AffordableHealthcare #ForYou #HealthNews #MedicalBreakthrough #Biosimilars #ForYouPage #FYP #HealthcareInnovation #Medicine #HealthUpdates #ForYou
Novo Nordisk acquires three Catalent sites to expand production capacity. Short-term dips, but big long-term benefits!
#pharmaupdates #PharmaNews #HealthNews #NovoNordisk #HealthcareInnovation #Biotech #Catalent #ForYouPage #FYP #Medicine #ForYou
#pharmaupdates #PharmaNews #HealthNews #NovoNordisk #HealthcareInnovation #Biotech #Catalent #ForYouPage #FYP #Medicine #ForYou
December 16, 2024 at 11:04 PM
Novo Nordisk acquires three Catalent sites to expand production capacity. Short-term dips, but big long-term benefits!
#pharmaupdates #PharmaNews #HealthNews #NovoNordisk #HealthcareInnovation #Biotech #Catalent #ForYouPage #FYP #Medicine #ForYou
#pharmaupdates #PharmaNews #HealthNews #NovoNordisk #HealthcareInnovation #Biotech #Catalent #ForYouPage #FYP #Medicine #ForYou
Catch up with the top pharma news in 30s of Pharma! This week: new drug advancements, regulatory milestones, and transformative treatments in healthcare. Stay tuned and follow for more!
#PharmaNews #Healthcare #Innovation #30sofPharma #DrugApproval #ClinicalTrials #GlobalHealth #RSV #HIV #Epilepsy
#PharmaNews #Healthcare #Innovation #30sofPharma #DrugApproval #ClinicalTrials #GlobalHealth #RSV #HIV #Epilepsy
December 14, 2024 at 2:12 AM
Catch up with the top pharma news in 30s of Pharma! This week: new drug advancements, regulatory milestones, and transformative treatments in healthcare. Stay tuned and follow for more!
#PharmaNews #Healthcare #Innovation #30sofPharma #DrugApproval #ClinicalTrials #GlobalHealth #RSV #HIV #Epilepsy
#PharmaNews #Healthcare #Innovation #30sofPharma #DrugApproval #ClinicalTrials #GlobalHealth #RSV #HIV #Epilepsy
Catch up with the top pharma news in 30s of Pharma! This week: new drug advancements, regulatory milestones, and transformative treatments in healthcare. Stay tuned and follow for more!
#PharmaNews #Healthcare #Innovation #30sofPharma #DrugApproval #ClinicalTrials #PharmaceuticalIndustry #RSV #HIV
#PharmaNews #Healthcare #Innovation #30sofPharma #DrugApproval #ClinicalTrials #PharmaceuticalIndustry #RSV #HIV
December 14, 2024 at 2:07 AM
Catch up with the top pharma news in 30s of Pharma! This week: new drug advancements, regulatory milestones, and transformative treatments in healthcare. Stay tuned and follow for more!
#PharmaNews #Healthcare #Innovation #30sofPharma #DrugApproval #ClinicalTrials #PharmaceuticalIndustry #RSV #HIV
#PharmaNews #Healthcare #Innovation #30sofPharma #DrugApproval #ClinicalTrials #PharmaceuticalIndustry #RSV #HIV
Neffy is a needle-free epinephrine spray for severe allergies, now seeking approval in China, Japan, and Australia. A life-changing innovation! #AllergyRelief #HealthBreakthrough #MedicalNews #PharmaUpdates #Neffy #LifeChanging #Allergies #Innovation #AllergyRelief #SevereAllergies #HealthNews
December 14, 2024 at 2:04 AM
Neffy is a needle-free epinephrine spray for severe allergies, now seeking approval in China, Japan, and Australia. A life-changing innovation! #AllergyRelief #HealthBreakthrough #MedicalNews #PharmaUpdates #Neffy #LifeChanging #Allergies #Innovation #AllergyRelief #SevereAllergies #HealthNews
IBRANCE® boosts survival by 15+ months for HR+/HER2+ metastatic breast cancer patients in a new study. A huge step forward! #BreastCancer #CancerResearch #IBRANCE #Pfizer #HealthNews #Breakthrough #OncologyUpdates #BreastCancer #Cancer #Tumor #CancerResearch #HealthBreakthrough #MedicalNews #Pfizer
December 14, 2024 at 2:03 AM
IBRANCE® boosts survival by 15+ months for HR+/HER2+ metastatic breast cancer patients in a new study. A huge step forward! #BreastCancer #CancerResearch #IBRANCE #Pfizer #HealthNews #Breakthrough #OncologyUpdates #BreastCancer #Cancer #Tumor #CancerResearch #HealthBreakthrough #MedicalNews #Pfizer
Big news for adults with growth hormone deficiency! SKYTROFA® may soon expand to help more people live healthier lives. Stay tuned for updates! #MedicalBreakthrough #HealthNews #FDAUpdate #GrowthHormoneDeficiency#HealthNews #GrowthHormone #MedicalInnovation #FDAApproval #FYP #MedicalBreakthrough
December 14, 2024 at 2:00 AM
Big news for adults with growth hormone deficiency! SKYTROFA® may soon expand to help more people live healthier lives. Stay tuned for updates! #MedicalBreakthrough #HealthNews #FDAUpdate #GrowthHormoneDeficiency#HealthNews #GrowthHormone #MedicalInnovation #FDAApproval #FYP #MedicalBreakthrough
Lynparza just showed long-term survival benefits for breast cancer patients after 6 years of follow-up. A huge step forward in treatment!
#breastcancer #CancerResearch #CancerTreatment #Lynparza #BRCA #HER2Negative #HopeForCancer #MedicalInnovation #PharmaNews #CancerAwareness #BreastCancer
#breastcancer #CancerResearch #CancerTreatment #Lynparza #BRCA #HER2Negative #HopeForCancer #MedicalInnovation #PharmaNews #CancerAwareness #BreastCancer
December 13, 2024 at 1:31 AM
Lynparza just showed long-term survival benefits for breast cancer patients after 6 years of follow-up. A huge step forward in treatment!
#breastcancer #CancerResearch #CancerTreatment #Lynparza #BRCA #HER2Negative #HopeForCancer #MedicalInnovation #PharmaNews #CancerAwareness #BreastCancer
#breastcancer #CancerResearch #CancerTreatment #Lynparza #BRCA #HER2Negative #HopeForCancer #MedicalInnovation #PharmaNews #CancerAwareness #BreastCancer
Baxter just launched 5 new injectable products to fight infections, cancer, GERD, and seizures! Ready-to-use for better patient care. #healthcareinnovation #Pharma #Injectables #Cancer #Seizures #GERD #Antibacterial #MedicalInnovation #Healthcare #Pharma #Injectables #CancerTreatment
December 13, 2024 at 1:28 AM
Baxter just launched 5 new injectable products to fight infections, cancer, GERD, and seizures! Ready-to-use for better patient care. #healthcareinnovation #Pharma #Injectables #Cancer #Seizures #GERD #Antibacterial #MedicalInnovation #Healthcare #Pharma #Injectables #CancerTreatment
AbbVie has acquired Aliada to accelerate the fight against Alzheimer’s with a new drug that targets the brain directly!
#neuroscience #healthcare #medicalnews #Alzheimers #AlzheimerTreatment #Neuroscience #PharmaNews #Healthcare #MedicalResearch #NewDrug #DrugDevelopment #BrainHealth #BigPharma
#neuroscience #healthcare #medicalnews #Alzheimers #AlzheimerTreatment #Neuroscience #PharmaNews #Healthcare #MedicalResearch #NewDrug #DrugDevelopment #BrainHealth #BigPharma
December 13, 2024 at 1:24 AM
AbbVie has acquired Aliada to accelerate the fight against Alzheimer’s with a new drug that targets the brain directly!
#neuroscience #healthcare #medicalnews #Alzheimers #AlzheimerTreatment #Neuroscience #PharmaNews #Healthcare #MedicalResearch #NewDrug #DrugDevelopment #BrainHealth #BigPharma
#neuroscience #healthcare #medicalnews #Alzheimers #AlzheimerTreatment #Neuroscience #PharmaNews #Healthcare #MedicalResearch #NewDrug #DrugDevelopment #BrainHealth #BigPharma
Astria Therapeutics' STAR-0310 could transform treatment for atopic dermatitis with its long-lasting effects. Find out more about this exciting new therapy!
#EczemaRelief #AtopicDermatitis #HealthNews #FDAApproval #MedicalBreakthrough #SkinCareInnovation #ScienceNews #HealthBreakthroughs
#EczemaRelief #AtopicDermatitis #HealthNews #FDAApproval #MedicalBreakthrough #SkinCareInnovation #ScienceNews #HealthBreakthroughs
December 11, 2024 at 9:23 PM
Astria Therapeutics' STAR-0310 could transform treatment for atopic dermatitis with its long-lasting effects. Find out more about this exciting new therapy!
#EczemaRelief #AtopicDermatitis #HealthNews #FDAApproval #MedicalBreakthrough #SkinCareInnovation #ScienceNews #HealthBreakthroughs
#EczemaRelief #AtopicDermatitis #HealthNews #FDAApproval #MedicalBreakthrough #SkinCareInnovation #ScienceNews #HealthBreakthroughs
SPI-1005 offers hope for Meniere’s disease by improving hearing, speech, and balance. The future of hearing health is here!
#HearingHealth #TinnitusRelief #MeniereDisease #HearingLoss #MedicalInnovation #ClinicalTrials #BreakingNews #HealthBreakthrough #ScienceMatters #HealthUpdates #FollowForMore
#HearingHealth #TinnitusRelief #MeniereDisease #HearingLoss #MedicalInnovation #ClinicalTrials #BreakingNews #HealthBreakthrough #ScienceMatters #HealthUpdates #FollowForMore
December 11, 2024 at 9:21 PM
SPI-1005 offers hope for Meniere’s disease by improving hearing, speech, and balance. The future of hearing health is here!
#HearingHealth #TinnitusRelief #MeniereDisease #HearingLoss #MedicalInnovation #ClinicalTrials #BreakingNews #HealthBreakthrough #ScienceMatters #HealthUpdates #FollowForMore
#HearingHealth #TinnitusRelief #MeniereDisease #HearingLoss #MedicalInnovation #ClinicalTrials #BreakingNews #HealthBreakthrough #ScienceMatters #HealthUpdates #FollowForMore
ZUPREME-1 is testing petrelintide, a weekly injection, for safe and effective weight management. A game-changer in the making!
#ObesityTreatment #WeightManagement #HealthBreakthrough #ZUPREME1 #Petrelintide #HealthNews #ClinicalTrials #ScienceMatters #MedicalInnovation #BreakingNews #HealthyLiving
#ObesityTreatment #WeightManagement #HealthBreakthrough #ZUPREME1 #Petrelintide #HealthNews #ClinicalTrials #ScienceMatters #MedicalInnovation #BreakingNews #HealthyLiving
December 11, 2024 at 9:19 PM
ZUPREME-1 is testing petrelintide, a weekly injection, for safe and effective weight management. A game-changer in the making!
#ObesityTreatment #WeightManagement #HealthBreakthrough #ZUPREME1 #Petrelintide #HealthNews #ClinicalTrials #ScienceMatters #MedicalInnovation #BreakingNews #HealthyLiving
#ObesityTreatment #WeightManagement #HealthBreakthrough #ZUPREME1 #Petrelintide #HealthNews #ClinicalTrials #ScienceMatters #MedicalInnovation #BreakingNews #HealthyLiving
AbbVie’s Tavapadon shows huge potential for Parkinson’s patients in early stages. A hopeful step in treating this challenging condition.
#Parkinsons #BrainHealth #Neurology #ParkinsonsDisease #HealthNews #MedicalBreakthrough #ScienceUpdates #NewMedicines #ClinicalTrials #DiseaseAwareness
#Parkinsons #BrainHealth #Neurology #ParkinsonsDisease #HealthNews #MedicalBreakthrough #ScienceUpdates #NewMedicines #ClinicalTrials #DiseaseAwareness
December 11, 2024 at 12:46 AM
AbbVie’s Tavapadon shows huge potential for Parkinson’s patients in early stages. A hopeful step in treating this challenging condition.
#Parkinsons #BrainHealth #Neurology #ParkinsonsDisease #HealthNews #MedicalBreakthrough #ScienceUpdates #NewMedicines #ClinicalTrials #DiseaseAwareness
#Parkinsons #BrainHealth #Neurology #ParkinsonsDisease #HealthNews #MedicalBreakthrough #ScienceUpdates #NewMedicines #ClinicalTrials #DiseaseAwareness
CARVYKTI® is redefining treatment for multiple myeloma with higher MRD-negativity rates. Hope is here!
#MultipleMyeloma #CancerResearch #CancerBreakthrough #CAR-T #HealthNews #HopeForPatients #ChronicIllness #MedicalInnovation #FDAApproved #Hematology #CancerCare #ScienceUpdates #HealthMatters
#MultipleMyeloma #CancerResearch #CancerBreakthrough #CAR-T #HealthNews #HopeForPatients #ChronicIllness #MedicalInnovation #FDAApproved #Hematology #CancerCare #ScienceUpdates #HealthMatters
December 11, 2024 at 12:44 AM
CARVYKTI® is redefining treatment for multiple myeloma with higher MRD-negativity rates. Hope is here!
#MultipleMyeloma #CancerResearch #CancerBreakthrough #CAR-T #HealthNews #HopeForPatients #ChronicIllness #MedicalInnovation #FDAApproved #Hematology #CancerCare #ScienceUpdates #HealthMatters
#MultipleMyeloma #CancerResearch #CancerBreakthrough #CAR-T #HealthNews #HopeForPatients #ChronicIllness #MedicalInnovation #FDAApproved #Hematology #CancerCare #ScienceUpdates #HealthMatters
Tonix’s TNX-102 SL shows promise as a non-opioid solution for fibromyalgia, improving pain and sleep. A hopeful step forward!
#Fibromyalgia #ChronicPain #HealthNews #MedicalBreakthrough #NonOpioid #BetterSleep #ScienceUpdates #ChronicIllness #FDAApproval #HopeForPatients #InvisibleIllness
#Fibromyalgia #ChronicPain #HealthNews #MedicalBreakthrough #NonOpioid #BetterSleep #ScienceUpdates #ChronicIllness #FDAApproval #HopeForPatients #InvisibleIllness
December 11, 2024 at 12:39 AM
Tonix’s TNX-102 SL shows promise as a non-opioid solution for fibromyalgia, improving pain and sleep. A hopeful step forward!
#Fibromyalgia #ChronicPain #HealthNews #MedicalBreakthrough #NonOpioid #BetterSleep #ScienceUpdates #ChronicIllness #FDAApproval #HopeForPatients #InvisibleIllness
#Fibromyalgia #ChronicPain #HealthNews #MedicalBreakthrough #NonOpioid #BetterSleep #ScienceUpdates #ChronicIllness #FDAApproval #HopeForPatients #InvisibleIllness
Recce Pharmaceuticals’ Phase 3 trial for R327G could transform diabetic foot infection treatments. A huge step for millions affected worldwide! #DiabetesCare #MedicalInnovation #Diabetes #MedicalBreakthrough #InfectionTreatment #HealthcareInnovation #ScienceNews #GlobalHealth #HealthUpdates
December 10, 2024 at 12:05 AM
Recce Pharmaceuticals’ Phase 3 trial for R327G could transform diabetic foot infection treatments. A huge step for millions affected worldwide! #DiabetesCare #MedicalInnovation #Diabetes #MedicalBreakthrough #InfectionTreatment #HealthcareInnovation #ScienceNews #GlobalHealth #HealthUpdates
AstraZeneca’s Calquence-venetoclax combo shows incredible results for CLL patients. A hopeful step forward in cancer care. #CancerBreakthrough #LeukemiaTreatmen #Cancer #BloodCancer #Leukemia #CancerTreatment #ChronicLymphocyticLeukemia #MedicalBreakthrough #ScienceNews #HealthUpdates
December 10, 2024 at 12:03 AM
AstraZeneca’s Calquence-venetoclax combo shows incredible results for CLL patients. A hopeful step forward in cancer care. #CancerBreakthrough #LeukemiaTreatmen #Cancer #BloodCancer #Leukemia #CancerTreatment #ChronicLymphocyticLeukemia #MedicalBreakthrough #ScienceNews #HealthUpdates